Optovue launches new corporate website

Article

Optovue announced the launch of The Optometric Medical Model Initiative (TOMMI), an optometric-focused educational program intended to help physicians successfully integrate the medical model into their practice.

Fremont, CA-Optovue announced the launch of The Optometric Medical Model Initiative (TOMMI), an optometric-focused educational program intended to help physicians successfully integrate the medical model into their practice.

The TOMMI Program is designed to facilitate increased physician awareness and education of the various aspects of the medical model through live workshops and symposia as well as recorded webinars, articles and presentations that are housed within the TOMMI Web Portal. 

Topics found on the Web portal include:

• Posterior eye diseases, including age-related macular degeneration, diabetic retinopathy, and glaucoma.

• Anterior segment, from the use of Pachymetry maps, angle measurements to the fitting of specialty contact lenses.

• Billing and coding.

• Pearls for the implementation of new technology into the primary eyecare practice

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
Neda Shamie, MD; Selina McGee, OD, FAAO, Dipl ABO; and Jacob Lang, OD, FAAO; provided their insights during CIME 2025 on May 4.
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
© 2025 MJH Life Sciences

All rights reserved.